GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Target Group Inc (OTCPK:CBDY) » Definitions » Debt-to-EBITDA

CBDY (Target Group) Debt-to-EBITDA : -5.71 (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Target Group Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Target Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $0.14 Mil. Target Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $1.09 Mil. Target Group's annualized EBITDA for the quarter that ended in Sep. 2024 was $-0.22 Mil. Target Group's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 was -5.71.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Target Group's Debt-to-EBITDA or its related term are showing as below:

CBDY' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.57   Med: -0.13   Max: 0.73
Current: 0.69

During the past 11 years, the highest Debt-to-EBITDA Ratio of Target Group was 0.73. The lowest was -0.57. And the median was -0.13.

CBDY's Debt-to-EBITDA is ranked better than
67.23% of 656 companies
in the Drug Manufacturers industry
Industry Median: 1.67 vs CBDY: 0.69

Target Group Debt-to-EBITDA Historical Data

The historical data trend for Target Group's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Target Group Debt-to-EBITDA Chart

Target Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 -0.27 0.73 -0.57 0.71

Target Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.54 1.14 0.82 0.27 -5.71

Competitive Comparison of Target Group's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Target Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Target Group's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Target Group's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Target Group's Debt-to-EBITDA falls into.



Target Group Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Target Group's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.128 + 1.224) / 1.899
=0.71

Target Group's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.144 + 1.089) / -0.216
=-5.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2024) EBITDA data.


Target Group  (OTCPK:CBDY) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Target Group Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Target Group's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Target Group Business Description

Traded in Other Exchanges
N/A
Address
20 Hempstead Drive, Hamilton, ON, CAN, L8W 2E7
Target Group Inc is engaged in the cultivation, processing, and distribution of curated cannabis products for the adult-use medical and recreational cannabis market in Canada. The company generates revenue from the sale of Wisp vaporizer and pod units.
Executives
Barry Alan Katzman director 36 ADDISON DRIVE, ST. CATHERINES A6 L2S 4B7
Anthony Carlo Zarcone director 564 NORTH SHORE BLVD., BURLINGTON A6 L7T 1X2
Frank Michael Monte director 18 BRAESIDE SQ, MARKHAM A6 L3R 0A5
Saul Niddam director 42 HEATHVIEW AVE, NORTH YORK A6 M2K 2C1
Azmatali Mehrali officer: CFO 134 BRIDGEPOINTE COURT, AURORA A6 L4H 3H8
Alexander Starr director, 10 percent owner, officer: President 1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
Rubin Schindermann director, 10 percent owner, officer: CEO 1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
Weinstein Family (2015) Trust 10 percent owner 52 RIDOUT STREET EAST, TILLSONBURG A6 N4G 2E3
Chess Supersite Inc. (canada) 10 percent owner 1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
Nava Starr other: See Remarks 1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
James M Cassidy director, 10 percent owner, officer: president 215 APOLENA AVENUE, NEWPORT BEACH CA 92662
James K Mckillop director, 10 percent owner, officer: vice president 9454 WILSHIRE BOULEVARD, SUITE 612, BEVERLY HILLS CA 90212

Target Group Headlines

From GuruFocus

Canary RX Receives its Health Canada Sales License

By PRNewswire PRNewswire 09-15-2021

Canary RX Announces Year to Date Wholesale Cannabis Sales

By PRNewswire PRNewswire 10-05-2021